$255 Million is the total value of DINSMORE CAPITAL MANAGEMENT CO/NJ's 146 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ACTPRA | New | Actavis PLCpfd cv | $4,048,000 | – | 4,000 | +100.0% | 1.58% | – |
| New | Cheniere Energy, Inc.conv | $2,484,000 | – | 3,000,000 | +100.0% | 0.97% | – | |
| New | SunEdison, Inc.conv | $2,355,000 | – | 2,000,000 | +100.0% | 0.92% | – | |
| New | Isis Pharmaceuticals, Inc.conv | $2,332,000 | – | 2,000,000 | +100.0% | 0.91% | – | |
| New | Global Eagle Entertainment Inconv | $2,211,000 | – | 2,250,000 | +100.0% | 0.87% | – | |
| AMTPRB | New | American Tower Corp.pfd cv | $1,985,000 | – | 20,000 | +100.0% | 0.78% | – |
| New | Emergent BioSolutions Inc.conv | $1,853,000 | – | 1,600,000 | +100.0% | 0.73% | – | |
| New | Jarden Corp.conv | $1,787,000 | – | 1,500,000 | +100.0% | 0.70% | – | |
| New | Cepheidconv | $1,783,000 | – | 1,600,000 | +100.0% | 0.70% | – | |
| New | Horizon Pharma Investment Ltdconv | $1,758,000 | – | 1,500,000 | +100.0% | 0.69% | – | |
| New | Jazz Pharmaceuticals plcconv | $1,660,000 | – | 1,420,000 | +100.0% | 0.65% | – | |
| New | Oclaro, Inc.conv | $1,223,000 | – | 1,000,000 | +100.0% | 0.48% | – | |
| New | inContact, Inc.conv | $1,210,000 | – | 1,150,000 | +100.0% | 0.47% | – | |
| New | ANI Pharmaceuticals, Inc.conv | $1,154,000 | – | 1,000,000 | +100.0% | 0.45% | – | |
| AFSI | New | AmTrust Financial Services, I | $1,146,000 | – | 20,110 | +100.0% | 0.45% | – |
| New | Microchip Technology Inc.conv | $1,043,000 | – | 1,000,000 | +100.0% | 0.41% | – | |
| UN | New | Unilever N.V. (ADR) | $1,002,000 | – | 24,000 | +100.0% | 0.39% | – |
| New | The Medicines Co.conv | $541,000 | – | 500,000 | +100.0% | 0.21% | – | |
| New | Brocade Communicationsconv | $527,000 | – | 500,000 | +100.0% | 0.21% | – | |
| HK | New | Halcon Resources Corp. | $11,000 | – | 7,414 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 10 | Q3 2015 | 3.3% |
| The Priceline Group Inc. | 10 | Q3 2015 | 1.9% |
| Wells Fargo & Co. | 10 | Q3 2015 | 2.1% |
| Huntington Bancshares, Inc. | 10 | Q3 2015 | 1.5% |
| Weyerhaeuser Co. | 10 | Q3 2015 | 1.4% |
| Mentor Graphics Corp. | 10 | Q3 2015 | 1.5% |
| Chesapeake Energy Corp. | 10 | Q3 2015 | 1.5% |
| CSG Systems International, Inc. | 10 | Q3 2015 | 1.3% |
| Colony Financial, Inc. | 10 | Q3 2015 | 1.1% |
| NY Community Capital Trust V | 10 | Q3 2015 | 1.0% |
View DINSMORE CAPITAL MANAGEMENT CO/NJ's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2015-10-20 |
| 4 | 2015-09-29 |
| 13F-HR | 2015-07-30 |
| 13F-HR | 2015-05-15 |
| 13F-HR | 2015-02-13 |
| 13F-HR | 2014-11-14 |
| 13F-HR | 2014-08-15 |
| 13F-HR | 2014-05-14 |
| 13F-HR | 2014-02-14 |
| 13F-HR | 2013-11-13 |
View DINSMORE CAPITAL MANAGEMENT CO/NJ's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.